An AI-guided platform at Penn Medicine allows clinicians to quickly and easily unearth pertinent information from patients’ ...
When a patient with renal cell carcinoma (RCC) progresses on or following the combination of a tyrosine kinase inhibitor (TKI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback